Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Endothelin Receptor Antagonist [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
AMBRISENTAN	86,197	10,291	11.9%	32,910	599	59.5 yrs	76.1%
MACITENTAN	45,325	9,886	21.8%	24,183	738	61.5 yrs	74.3%
BOSENTAN	19,581	4,346	22.2%	8,862	303	52.5 yrs	73.2%
SPARSENTAN	3,280	18	0.5%	209	2	49.3 yrs	43.8%
APROCITENTAN	10	0	N/A	3	0	61.0 yrs	36.4%

Head-to-Head Comparisons

AMBRISENTAN vs MACITENTAN AMBRISENTAN vs BOSENTAN AMBRISENTAN vs SPARSENTAN AMBRISENTAN vs APROCITENTAN MACITENTAN vs BOSENTAN MACITENTAN vs SPARSENTAN MACITENTAN vs APROCITENTAN BOSENTAN vs SPARSENTAN BOSENTAN vs APROCITENTAN SPARSENTAN vs APROCITENTAN

← Back to Endothelin Receptor Antagonist [EPC] Class side effects →